About Engine Biosciences
Engine Biosciences is a company based in Singapore (Singapore) founded in 2014.. Engine Biosciences has raised $80 million across 3 funding rounds from investors including WuXi AppTec, WI Harper Group and Polaris Partners. The company has 5 employees as of December 31, 2024. Engine Biosciences offers products and services including Science Platform and Therapeutics Pipeline. Engine Biosciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Formation Bio, Sutro Biopharma and Antheia, among others.
- Headquarter Singapore, Singapore
- Employees 5 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Engine Biosciences Pte. Ltd.
-
Annual Revenue
$14.41 K0as on Dec 31, 2019
-
Net Profit
$-12.94 M-49as on Dec 31, 2021
-
EBITDA
-
Total Equity Funding
$80 M (USD)
in 3 rounds
-
Latest Funding Round
$27 M (USD), Series A
Oct 31, 2023
-
Investors
WuXi AppTec
& 14 more
-
Employee Count
5
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Engine Biosciences
Engine Biosciences offers a comprehensive portfolio of products and services, including Science Platform and Therapeutics Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrates ML for identifying genetic interactions in diseases.
Advances targeted therapies for solid tumors and biomarkers.
Unlock access to complete
Unlock access to complete
Funding Insights of Engine Biosciences
Engine Biosciences has successfully raised a total of $80M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $27 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $27.0M
-
First Round
First Round
(31 Jan 2018)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Series A - Engine Biosciences | Valuation | Polaris Partners | |
| May, 2021 | Amount | Series A - Engine Biosciences | Valuation | Polaris Partners | |
| Jan, 2018 | Amount | Seed - Engine Biosciences | Valuation | 6 Dimensions Capital , DHVC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Engine Biosciences
Engine Biosciences has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include WuXi AppTec, WI Harper Group and Polaris Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Long-term private equity investments in transformational opportunities are pursued.
|
Founded Year | Domain | Location | |
|
Government-backed investments are directed toward healthcare, fintech, and various sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Engine Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Engine Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Engine Biosciences Comparisons
Competitors of Engine Biosciences
Engine Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Formation Bio, Sutro Biopharma and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Engine Biosciences
Frequently Asked Questions about Engine Biosciences
When was Engine Biosciences founded?
Engine Biosciences was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Where is Engine Biosciences located?
Engine Biosciences is headquartered in Singapore, Singapore.
Is Engine Biosciences a funded company?
Engine Biosciences is a funded company, having raised a total of $80M across 3 funding rounds to date. The company's 1st funding round was a Seed of $10M, raised on Jan 31, 2018.
How many employees does Engine Biosciences have?
As of Dec 31, 2024, the latest employee count at Engine Biosciences is 5.
What is the annual revenue of Engine Biosciences?
Annual revenue of Engine Biosciences is $14.41K as on Dec 31, 2019.
What does Engine Biosciences do?
Engine Biosciences was founded in 2014 in Singapore. A platform technology is provided for discovering novel gene and drug combinations in biotechnology. Ultra-high-throughput screens are enabled to identify combinatorial effects on targeted phenotypes. Operations focus on therapeutic and industrial applications within the genetics sector. The domain enginebio.com is maintained for related activities.
Who are the top competitors of Engine Biosciences?
Engine Biosciences's top competitors include Owkin, Sutro Biopharma and Synthego.
What products or services does Engine Biosciences offer?
Engine Biosciences offers Science Platform and Therapeutics Pipeline.
Who are Engine Biosciences's investors?
Engine Biosciences has 15 investors. Key investors include WuXi AppTec, WI Harper Group, Polaris Partners, ClavystBio, and Invus.